- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
International Journal of Microbiology
Volume 2011 (2011), Article ID 463096, 9 pages
Suitability of Commercial Transport Media for Biological Pathogens under Nonideal Conditions
1Excet, Inc., 8001 Braddock Rd Suite 303, Springfield, VA 22151, USA
2Edgewood Chemical Biological Center, U.S. Army, RDECOM, Edgewood Area, Aberdeen Proving Ground, MD 21010, USA
3Noblis, Inc., 3150 Fairview Park Drive, Falls Church, VA 22042, USA
Received 8 June 2011; Revised 24 August 2011; Accepted 4 September 2011
Academic Editor: Mumtaz Virji
Copyright © 2011 Kyle Hubbard et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
There is extensive data to support the use of commercial transport media as a stabilizer for known clinical samples; however, there is little information to support their use outside of controlled conditions specified by the manufacturer. Furthermore, there is no data to determine the suitability of said media for biological pathogens, specifically those of interest to the US military. This study evaluates commercial off-the-shelf (COTS) transport media based on sample recovery, viability, and quality of nucleic acids and peptides for nonpathogenic strains of Bacillus anthracis, Yersinia pestis, and Venezuelan equine encephalitis virus, in addition to ricin toxin. Samples were stored in COTS, PBST, or no media at various temperatures over an extended test period. The results demonstrate that COTS media, although sufficient for the preservation of nucleic acid and proteinaceous material, are not capable of maintaining an accurate representation of biothreat agents at the time of collection.
The anthrax attacks of 2001 highlighted gaps in the US bio-terrorism related preparedness . The large numbers of incoming samples overwhelmed on-site mobile laboratories and required shipping sample off-site for analysis of viability in support of large-scale remediation activities such as those that occurred at the Brentwood Postal Offices and the Hart Senate Office building . On-site sample extracts were stored in water at 4°C or −20°C for longer storage times. For off-site analysis, swabs were shipped dry on ice. Retrospective analysis of the events clearly indicates that a lack of standardized collection and processing techniques for environmental samples complicated contamination and clean-up assessment [1, 3]. Biological remediation activities, longitudinal clinical studies, and verification activities in support of military and treaty exploitation each share a common theme—a requirement to collect samples and preserve them for examination and analysis at a future date. In situations where samples must be analyzed by offsite laboratories, significant time can elapse between when a sample is collected and when it is analyzed. In these situations a biological sample will often lose viability for re-growth or degrade and denature which makes subsequent analysis by PCR or immunoassay more difficult. It is imperative to have a process for short- and long-term storage that is efficient and preserves sample integrity over time. For collection teams that support military or international treaty verification organizations, that need is further complicated by the difficulty in maintaining the cold chain, the highly pathogenic nature of samples that may need to be collected, and in the great distances that a sample may need to be shipped until it can be analyzed by a properly equipped laboratory. The use of commercially available collection and transport media is attractive due to their worldwide availability and low price.
The following study was conducted to assess the potential for one type of commercially available collection and transport system that was developed for clinical samples and to determine its potential to be adapted for use with four prototypical agents of biological origin that may be of interest to military and treaty verification organizations. Each transport system contained a sterile, rayon-tipped swab applicator used to collect the sample and a tube containing transport medium into which the swab applicator is placed after sampling. We examined the use of these particular COTS transport media for their ability to maintain organism or toxin viability, as well as their suitability for maintaining detectable levels of nucleic acid and protein over a range of environmental conditions.
The agents chosen for this study included Bacillus anthracis, a gram-positive endospore-forming species and the non-spore-forming, gram-negative Yersinia pestis. Strains with reduced pathogenicity (Bacillus anthracis Sterne and Yersinia pestis A1122, resp.) were used for testing. The vegetative form of B. anthracis was used because spores do not require liquid transport medium for stabilization. However, the suitability of transport media for preserving vegetative cells has not been determined. In addition, given the expansion in global biosurveillance, the utility of these COTS kits for environmental sampling may not be limited to traditional weapons and spore deposition, but could have applicability for animal carcasses or human patients where the vegetative form would prevail. The ricin holotoxin purified from defatted castor beans was the protein toxin bio-threat agent tested. Venezuelan equine encephalitis (VEE) virus was chosen as an example of an enveloped and single-stranded RNA virus as well, being associated with human disease. The TC-83 vaccine strain of VEE was chosen for testing due to its lower pathogenicity.
2. Materials and Methods
2.1. Biological Agents, Mediums, and Growth Conditions
All chemicals were molecular grade and purchased from Fisher Scientific (Suwanee, Ga, USA). Bacillus anthracis (Sterne strain) and Yersinia pestis A1122 (YPA1122) were obtained from the Critical Reagents Program (CRP) (Aberdeen Proving Ground, Md, USA). The Sterne strain was streaked out on TSA plates (Becton Dickinson Inc. Franklin Lakes, NJ), and colonies appeared following incubation at 37°C for 24 hours. A single colony was added to 5 mL of sterile TSB (Remel Inc., Lenexa, KS) and allowed to grow at 37°C with rotary aeration at 180 rpm for 24 hours. The culture was expanded by taking 1 mL from the starter culture and adding it to 500 mL sterile TSB. The culture was allowed to grow at 37°C at 180 rpm for 16–24 hours. Growth of YPA1122 followed a similar course with the exceptions that the cultures were incubated at 30°C for 42–48 hours. Venezuelan equine encephalitis TC-83 virus was obtained from the Critical Reagents Program (Aberdeen Proving Ground, Md, USA). The frozen stock had a concentration of 4 × 107 pfu/mL in cell-freezing medium (catalog number 12648-010, Invitrogen Inc., Carlsbad, Calif, USA). Cell culture supplies were obtained from VWR international (West Chester, Pa, USA). Virus titer was determined by plaque assay in a Vero cell line obtained from the American Type Culture Collection (ATCC, catalog number CCL-81, Manassas, Va, USA). Each well of a six-well microtiter plate was loaded with 5 × 105 Vero cells (2.5 × 105/mL) the previous day and allowed to incubate overnight at 37°C with 5% CO2 and 100% humidity before the virus was introduced. After the one hour incubation at 37°C with mild shaking, the virus was removed and 2 mL of a 1 : 1 mixture of 2× Modified Eagles Medium (MEM) (catalog number 11935-046, Invitrogen, Carlsbad, Calif, USA) and 2% seaPlaque agarose (catalog number 12001-898, Cambrex, Charles City, Iowa, USA) were overlaid. The mixture was left at room temperature until solid, followed by incubation for 48 hours at 37°C 5% with CO2 and 100% humidity. Ricinus communis agglutinin II (RCA 60, Ricin), 5 mg/mL in 10 mM phosphate, 150 mM NaCl, pH 7.8 with 0.08% sodium azide as a preservative was purchased from Vector Laboratories (Burlingame, Calif, USA). The ricin was stored at 4°C when not in use.
2.2. Swab Preparation
The bacterial cultures were centrifuged at 2200 rcf for ten minutes at 10°C in order to pellet cells. The cell pellets were then washed in 10 mL phosphate buffered saline, 14 mM NaCl, 0.3 mM KCl, 1 mM Na2HPO4, 2 mM KH2PO4 (pH 7.4) w/0.1% Triton X-100 (PBST) before being resuspended in a small volume of PBST to generate a bacterial loading stock. In order to get a preliminary determination of concentration, the bacterial stock was diluted in PBS and optical density was determined using a Spec 20D+ spectrophotometer (Thermo Fisher Scientific Inc., Waltham, Mass, USA) at a wavelength of 600 nm and compared to a standard curve derived from known bacterial concentrations. The stock was then diluted in PBST in accordance with spectrophotometer data to obtain a concentration of approximately 3 × 108 cfu/mL and 1.6 × 109 cfu/mL for B. anthracis Sterne and YPA1122, respectively. 100 μL of the stock was then absorbed onto a rayon swab which was then placed into a tube containing transport media. In addition to testing the following media: PBST, liquid Amies (catalog number 140C), and liquid Stuart (catalog number 141C), swabs were also placed into dry tubes (catalog number 155C). All transport media were purchased from Copan Diagnostics Inc. (Corona, Calif, USA), except for PBST, which was prepared on site in sterile empty transport tubes. Swabs were tested in duplicate for each time point and temperature. Control swabs for each time point were loaded with 100 μL PBST, but were incubated only at 25°C.
Two ricin stocks were created by diluting with sterile-filtered distilled water to a final concentration of 5 μg/mL for the high spike experiment (HS), and 50 ng/mL for the low spike (LS) experiment. Rayon swabs were spiked with 100 μL of the high concentration or low concentration, thereby loading 500 ng and 5 ng ricin per swab, respectively. Three transport conditions were examined: sterile water, dryness, and protein transport medium (PTM). PTM is made up of 0.1% BSA and 1.0% Triton X-100 in sterile water and was made in-house. For the liquid transport media, one milliliter of each was added to sterile transport tubes containing a sponge (kindly provided by Copan Diagnostics Brescia, Italy).
The VEE TC-83 frozen stock was diluted 1 : 20 using Earl’s modified eagle’s medium (EMEM), catalog number 30-2003 (ATCC, Manassas, Va, USA). 100 μL of the 2 × 106 pfu/mL loading stock was absorbed onto rayon swabs which were then cut off into plastic tubes containing 3 mL M4RT (Remel, catalog number R12505) or UTM (Copan, catalog number 402C) viral transport media as well as PBST and tubes containing no transport medium (dry). Each tube also had three 1mm glass beads to aid in extraction. In addition, one control swab for each transport medium was loaded with 100 μL PBST.
2.3. Viability Testing
Swabs spiked with Bacillus anthracis Sterne and Yersinia pestis A1122 were stored at one of four temperatures (−70°C, 4°C, 25°C, or 45°C) for up to 60 days. Two swabs were removed per time point and the swab heads extracted by vortexing on a large area mixer (70% maximum pulse, for two minutes) in 5 mL PBST. For day 0, extractions and swabs were processed within one hour of being loaded so as to avoid irreversible binding to swab heads. 100 μL of the extract was serially diluted in PBST and plated onto tryptic soy agar plates in triplicate. In addition to quantifying the viable titer associated with the swab, the residual transport media was also serially diluted in PBST to determine if viable organisms diffused from the rayon into the transport media. Bacillus anthracis Sterne was incubated for 16–24 hours at 37°C, while Yersinia pestis A1122 was incubated for 42–48 hours at 30°C, after which colonies were counted using the Q-Count colony counter (Advanced Instruments Inc, Norwood, Mass, USA) to determine bacterial concentration.
Swabs spiked with VEE virus were stored at three temperatures (−70°C, 4°C, or 25°C) for up to 21 days. Virus was extracted directly from the transport tube by vortexing for two minutes (dry swabs were extracted in 3 mL sterile deionized water). 100 μL transport medium was serially diluted in 900 μL EMEM. 500 μL of each dilution was added to the Vero cells as described above to determine viral titer.
2.4. ECL Immunochemistry
The protein signature of the bacteria, virus, and toxin was determined using the BioVeris Inc M1M electrochemiluminescence (ECL) system (Gaithersburg, M, USA). ECL minitube immunoassays were purchased from the Critical Reagents Program (CRP) (Aberdeen Proving Grounds, Md, USA). The assays use two antibodies specific for the antigen of interest in a single-tube lyophilized reagent format. In addition, positive controls include a low-quantity (PCL) and a moderate-quantity (PCM) of positive control protein. This allows each of the stored samples to be semiquantitatively analyzed in comparison to the positive controls. Swab head extract (100 μL) was added directly to the lyophilized reagents. The M1M is completely automated and performs all incubations and reagent additions according to a preprogrammed methodology for each assay. B. anthracis Sterne, Y. pestis A1122, ricin, and VEE extracts were all assayed using ECL MINItubes available from the CRP.
2.5. Real-Time PCR
Real-time PCR was utilized for nucleic acid detection. B. anthracis Sterne and Y. pestis A1122 were assayed on the Roche LightCycler 2.0 using the Idaho Technologies (Salt Lake City, Utah, USA) B. anthracis Sterne Target 1 kit (catalog number 3828) and Y. pestis A1122 Target 1 kit (catalog number 3831), respectively. The real-time PCR assay for the test samples consisted of 20 μL of the swab head extract and 20 μL of kit reconstitution buffer added to the lyophilized reagents.
Viral nucleic acid detection was achieved using the Idaho Technologies JBAIDS Kit catalog number JRPD-ASY-0114. All real-time PCR assays were used according to manufacturers’ recommendations. The viral swab extracted was diluted 10-fold with water, and 40 μL of the diluted sample was added to reconstitute the lyophilized real-time PCR reagents. Crossing points were determined using the LightCycler 4.0 software algorithm (Roche Diagnostics, Indianapolis, Ind, USA).
3.1. Effect of Nonideal Storage Conditions on Biothreat Agent Viability
All data is expressed as percentage recovery relative to the total specimen loaded onto the swab head on day 0. In order to capture and quantify the total amount of viable organism present at a specific time point, the values representing the total of the extractions from the swab heads and from the residual transport media are shown in Table 1.
3.1.1. Bacillus anthracis Sterne
Temperature appeared to exert the greatest influence on the viability of B. anthracis Sterne. The highest recovery rates were measured for samples stored at 25°C in liquid Amies, liquid Stuart, and PBST (Table 1). Viability was also observed under dry storage conditions at that temperature. Storage at 4°C and 45°C resulted in the greatest loss of viability for all media tested by day 60 (Table 1). Swabs stored at −70°C did result in an initial decrease in viability of greater than 96% for all transport media; however, stronger long-term viability was observed over the 60-day test period than storage at either 4°C or 45°C (Table 1). B. anthracis stored at 25°C in both liquid Amies and liquid Stuart resulted in an increase in mean recovery starting on day 3 (Table 1). The samples were visualized using phase-contrast microscopy (see supplemental data available online at doi:10.1155/2dl/463096), which showed the increase in recovery was the result of sporulation of bacilli chains into individual spores rather than germination.
3.1.2. Yersinia pestis A1122
Like B. anthracis, recovery of Y. pestis was largely dependent on temperature and storage media. Y. pestis viability was best preserved at 4°C in liquid Stuart, displaying a 68% reduction in original load material, while viability in PBST decreased by 97.4% and viability in liquid Amies decreased by 90% after 60 days. All transport media failed to maintain appreciable viability after 60 days at 25°C (Table 1). PBST did not preserve viability as well as Stuart and Amies at 45°C with no viability detected after one day. Stuart and Amies were able to maintain detectable viability for at least 24 hours at 45°C. Swabs stored at −70°C in both liquid Amies and liquid Stuart showed the ability to maintain long-term viability. Freezing did cause an initial decrease in viability before day 1 for all transport media conditions; however, viability remained static in liquid Amies and liquid Stuart and under dry conditions after that during the 60-day test period (Table 1). Dry storage exhibited a compete loss of viability after 14 days at 25°C and a near-complete loss of viability by 28 days at 4°C.
Overall, viability was higher when samples were stored at colder temperatures in URM and M4RT (Table 1). No viable virus was recovered from swabs stored in PBST at any temperature. At −70°C, virus survival was aided when stored in UTM and M4RT, exhibiting a higher rate of recovery than samples stored on dry swabs across the 21-day test period (Table 1). The recovery efficiency for UTM and M4RT virus transport media was also pronounced for samples stored at 4°C where there was no viable virus in either PBST or under dry conditions (Table 1). Storage at 30°C was largely inhibitory to recovery of virus. UTM preserved VEE viability for only 7 days while none of the other transport methods were positive for viable virus, although that result is highly variable.
3.2. Nucleic Acid Detection of Bacterial Biothreat Agents Using Real-Time PCR
The Real-Time PCR data was consistent without any significant observable increases or decreases in recoverable genetic material across all storage conditions and time points, independent of biothreat agent tested; therefore, data will be presented as supplemental.
3.3. ECL Immunodetection of Bacterial Biothreat Agents
A four plus system was used to indicate the number of tests that were positive according to ECL immunodetection. Duplicate swabs were extracted at each time point and set up into duplicate detection assays. Thus, there were a total of four luminescent readings by which to assess whether a sample was positive (+) or negative (−) for agent detection.
3.3.1. B. anthracis Sterne
Protective antigen, the protein detected by this particular ECL kit, was universally detected at −70°C, but not detected at all at 45°C, regardless of the presence of transport media or the storage temperature (Table 2). A positive signal was detected on day 1 at 4°C for all storage conditions but was absent by day 7, except under dry swab conditions which had detectable amounts of protective antigen throughout the course of the study. In addition, only PBST and liquid Stuart showed any positive protein detection at 25°C and only on day 1 (Table 2).
3.3.2. Y. pestis A1122
All Y. pestis samples were positive over the time course regardless of the storage temperature (Table 2).
The ECL results were consistently positive throughout the 21-day time course. VEE viral protein was detectable for all time points and under all storage conditions; this despite the lack of a viable virus in PBST (Tables 1 and 2).
Ricin holotoxin was detected using an ECL-based immunoassay as described above. Using the 500 ng high spike concentration (HS) resulted in a much different relative luminescence signal when compared to the 5 ng low spike concentration (LS) (Table 3). This was true regardless of the absence or presence of transport buffer and at all storage temperatures examined. Protein transport media (PTM) almost universally provided the most robust detection levels (Table 3) at every temperature and time point. However, storage in water also resulted in comparable detection levels to storage in PTM at 25°C (Table 3). As the temperature increased from −70°C to 45°C, the immunodetection of ricin holotoxin decreased (Table 3) in all transport media. Most striking is the fact that ricin protein was detectable from the high spiked swabs throughout the 60-day time course when stored at 45°C in liquid transport media (Table 3).
An exhaustive number of studies have examined the efficacy of various sampling kits and techniques for removing bio-threat agents from a wide range of environmental conditions, while others still explored the efficacy of different transport media on the viability of bacterial samples [4–18]. This study evaluates unmodified commercial off-the-shelf (COTS) transport media based on sample recovery, viability, and quality of nucleic acid and peptides for nonpathogenic strains of B. anthracis Sterne, Y. pestis A1122, VEE, and ricin over a 60-day period. The results reported here demonstrate that COTS media evaluated here are not capable of maintaining an accurate representation of the quantity of biothreat agent at the time of collection.
A comparison between B. anthracis and Y. pestis enumeration over the 60-day test period clearly shows that while total numbers of B. anthracis colony counts increase, the Y. pestis counts decrease. This difference is likely attributable to how each organism responds to stress in a nutrient-deleted environment . Higher temperatures and the presence of liquid Amies or Stuart transport media, which are both nutrient poor, promoted sporulation . Lower temperatures inhibited B. anthracis Sterne sporulation, which in turn resulted in a rapid loss of viability of the vegetative cells. This suggests that long-term storage at elevated temperatures diminishes recovery of viable organisms except for microorganisms capable of sporulation in nutrient-poor transport media. Unfortunately, if a sample slowly converts from the vegetative to the spore state, the sample which is analyzed in the lab is not accurately portraying the sample that was originally collected on the swab at time zero. Downstream forensic lab analyses that require an accurate snapshot of the original sample at time zero will require a transport medium that contains sporulation inhibitors while maintaining vegetative cell viability.
The ECL protein detection assay for Y. pestis A1122 was more robust than the same assay for B. anthracis Sterne. Using the Y.-pestis-antibody-based ECL assay, it was possible to detect protein for weeks after loss of viability. This is vividly apparent for Y. pestis A1122 spiked samples stored at 45°C. In contrast, B. anthracis protective antigen were only detected for a short period of time from samples stored at −70°C. The differences observed in protein signature detection between Y. pestis A1122 and B. anthracis Sterne was also likely due to the latter’s ability to sporulate. Protective antigen will not be as widely expressed in B. anthracis in a sporulative state, as general transcription and translation become dormant [21–23]. If protein signature detection using ECL was performed on spore coat proteins on day 60, the results would likely look markedly different from those observed in this study using protective antigen and needs to be addressed in future studies.
The results from the real-time PCR assay were similar to those seen with the ECL assay; there was no correlation with viability. There were detectable levels of nucleic acid for all transport media at every temperature over the 60-day test period for both Y. pestis and B. anthracis.
Storage of VEE virus in viral transport media is required if any viability is to be maintained after seven days unless the sample is frozen. Even for frozen storage, the commercial viral transport media M4RT and UTM provided significantly better recovery than storage in PBST or under dry conditions. The rapid loss in VEE virus viability when stored in PBST is likely due to the disruption of the viral envelope by the presence of detergent .
Viral protein stability was not enhanced by either M4RT or UTM; however, dry storage did reduce viral protein recovery when not stored frozen. No definitive conclusions can be drawn for the viral nucleic acid signature stability from the data collected, except that protein was detectable for all temperature and storage conditions during the 21-day test.
Reverse-transcription real-time PCR specific for VEE revealed detectable amounts of nucleic acid for all transport media at every temperature over the 21-day test period. This was in stark contrast to the viability results, demonstrating live organism is not absolutely necessary for nucleic acid detection.
This series of experiments demonstrates that VEE viability is more sensitive to storage conditions than detection of the molecular targets using ECL or reverse-transcription real time PCR assays. Viability studies should be expanded to determine more precisely how long VEE can be recovered from samples stored at 4°C in transport media since by day 21, very little drop in titer was recorded. Additional time points should also be examined for samples stored at 30°C to more precisely determine the rate of virus decay at this temperature in virus transport media. The time course studies should also be extended for the ECL and real-time PCR assays.
Storing ricin-contaminated swabs in PTM or water while refrigerated or frozen resulted in higher protein detection than dry swabs under the same conditions at the completion of the 60-day test period. However, due to the limited number of samples and semiqualitative nature of the assay, further testing and ricin activity assays would be required to determine if a significant difference exists between sterile water and PTM in protein signature stability. Frozen storage at −70°C provided the best stability as evidenced by the consistent detection of the lightly contaminated swabs. For some of the storage conditions, there was ricin present at day 60 after it appeared to have been undetectable by day 28, although this is likely an artifact of the experimental design. As ricin has no reproductive capabilities, the increase in detectable material at day 60 is likely due to the evaporation of the buffer used to spike the ricin onto the swab artificially increasing the concentration, although more data between days 28 and 60 would be needed to support this claim. Furthermore, because of the ECL in an immunological assay, there is no way to tell if the ricin detected at day 60 was active.
This study evaluated the use of common COTS transport and stabilization swab systems for various biothreat agents. The results demonstrate that these type of COTS transport systems, typically used in clinical settings, can be useful in storage and transport of biothreat agents in environmental settings where conditions may be less than ideal only if obtaining a “yes” or “no” answer is sufficient and sensitive molecular assays are available. The viability studies conducted suggest that the types of COTS transport and stabilization tested are not capable of maintaining an accurate representation of the biothreat agent at the time of collection and should not be used for forensic analyses. This is especially true for spore-forming bacteria. Future transport media design will need to address this issue.
The authors express their special thanks to Kakoli Kim at Booze and Allen Hamilton and Sarah Katoski of SAIC at the US Army Edgewood Chemical Biological Center for helping to prepare this manuscript.
- E. H. Teshale, J. Painter, G. A. Burr et al., “Environmental sampling for spores of Bacillus anthracis,” Emerging Infectious Diseases, vol. 8, no. 10, pp. 1083–1087, 2002.
- J. A. Higgins, M. Cooper, L. Schroeder-Tucker et al., “A field investigation of Bacillus anthracis contamination of U.S. Department of agriculture and other Washington, D.C., buildings during the anthrax attack of October 2001,” Applied and Environmental Microbiology, vol. 69, no. 1, pp. 593–599, 2003.
- D. A. Canter, “Addressing residual risk issues at anthrax cleanups: how clean is safe?” Journal of Toxicology and Environmental Health A, vol. 68, no. 11-12, pp. 1017–1032, 2005.
- P. P. Bourbeau and B. J. Heiter, “Evaluation of copan swabs with liquid transport media for use in the gen-probe group a strep direct test,” Journal of Clinical Microbiology, vol. 41, no. 6, pp. 2686–2689, 2003.
- M. P. Buttner, P. Cruz-Perez, and L. D. Stetzenbach, “Enhanced detection of surface-associated bacteria in indoor environments by quantitative PCR,” Applied and Environmental Microbiology, vol. 67, no. 6, pp. 2564–2570, 2001.
- M. P. Buttner, P. Cruz, L. D. Stetzenbach, A. K. Klima-Comba, V. L. Stevens, and P. A. Emanuel, “Evaluation of the biological sampling kit (BiSKit) for large-area surface sampling,” Applied and Environmental Microbiology, vol. 70, no. 12, pp. 7040–7045, 2004.
- M. P. Buttner, P. Cruz, L. D. Stetzenbach, and T. Cronin, “Evaluation of two surface sampling methods for detection of Erwinia herbicola on a variety of materials by culture and quantitative PCR,” Applied and Environmental Microbiology, vol. 73, no. 11, pp. 3505–3510, 2007.
- C. G. Cumming and P. W. Ross, “Evaluation of bacteriologic swabs and transport media in the recovery of group B streptococci on laboratory media,” Journal of Clinical Pathology, vol. 32, no. 10, pp. 1066–1069, 1979.
- S. M. Da Silva, J. J. Filliben, and J. B. Morrow, “Parameters affecting spore recovery from wipes used in biological surface sampling,” Applied and Environmental Microbiology, vol. 77, no. 7, pp. 2374–2380, 2011.
- C. Drake, J. Barenfanger, J. Lawhorn, and S. Verhulst, “Comparison of easy-flow copan liquid Stuart's and starplex swab transport systems for recovery of fastidious aerobic bacteria,” Journal of Clinical Microbiology, vol. 43, no. 3, pp. 1301–1303, 2005.
- J. M. Edmonds, “Efficient methods for large-area surface sampling of sites contaminated with pathogenic microorganisms and other hazardous agents: current state, needs, and perspectives,” Applied Microbiology and Biotechnology, vol. 84, no. 5, pp. 811–816, 2009.
- J. M. Edmonds, P. J. Collett, E. R. Valdes, E. W. Skowronski, G. J. Pellar, and P. A. Emanuel, “Surface sampling of spores in dry-deposition aerosols,” Applied and Environmental Microbiology, vol. 75, no. 1, pp. 39–44, 2009.
- D. A. Frawley, M. N. Samaan, R. L. Bull, J. M. Robertson, A. J. Mateczun, and P. C. Turnbull, “Recovery efficiencies of anthrax spores and ricin from nonporous or nonabsorbent and porous or absorbent surfaces by a variety of sampling methods,” Journal of Forensic Sciences, vol. 53, no. 5, pp. 1102–1107, 2008.
- L. Rose, B. Jensen, A. Peterson, S. N. Banerjee, and M. J. Arduino, “Swab materials and Bacillus anthracis spore recovery from nonporous surfaces,” Emerging Infectious Diseases, vol. 10, no. 6, pp. 1023–1029, 2004.
- P. W. Ross, C. G. Cumming, and H. Lough, “Swabs and swab-transport media kits in the isolation of upper respiratory bacteria,” Journal of Clinical Pathology, vol. 35, no. 2, pp. 223–227, 1982.
- K. G. Van Horn and I. Rankin, “Evaluation and comparison of two Stuart's liquid swab transport systems tested by the CLSI M40 method,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 26, no. 8, pp. 583–586, 2007.
- K. G. Van Horn, C. D. Audette, K. A. Tucker, and D. Sebeck, “Comparison of 3 swab transport systems for direct release and recovery of aerobic and anaerobic bacteria,” Diagnostic Microbiology and Infectious Disease, vol. 62, no. 4, pp. 471–473, 2008.
- K. G. Van Horn, C. D. Audette, D. Sebeck, and K. A. Tucker, “Comparison of the copan ESwab system with two Amies agar swab transport systems for maintenance of microorganism viability,” Journal of Clinical Microbiology, vol. 46, no. 5, pp. 1655–1658, 2008.
- H. Noguchi, “On the inhibitory influence of eosin upon sporulation,” The Journal of Experimental Medicine, vol. 10, no. 1, pp. 30–35, 1908.
- P. J. Piggot and J. G. Coote, “Genetic aspects of bacterial endospore formation,” Bacteriological Reviews, vol. 40, no. 4, pp. 908–962, 1976.
- C. Bongiorni, R. Stoessel, and M. Perego, “Negative regulation of Bacillus anthracis sporulation by the Spo0E family of phosphatases,” Journal of Bacteriology, vol. 189, no. 7, pp. 2637–2645, 2007.
- H. Liu, N. H. Bergman, B. Thomason et al., “Formation and composition of the Bacillus anthracis endospore,” Journal of Bacteriology, vol. 186, no. 1, pp. 164–178, 2004.
- E. Saile and T. M. Koehler, “Control of anthrax toxin gene expression by the transition state regulator abrB,” Journal of Bacteriology, vol. 184, no. 2, pp. 370–380, 2002.
- R. G. Webster and R. W. Darlington, “Disruption of myxoviruses with Tween 20 and isolation of biologically active hemagglutinin and neuraminidase subunits,” Journal of Virology, vol. 4, no. 2, pp. 182–187, 1969.